Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Correard

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annales De Dermatologie Et De Venereologie|November 11, 2023
The value of pharmaceutical expertise in the detection and management of drug interactions with targeted therapies in melanomaB Demarez, C Gaudy, F Amatore, et al.
La Revue De Medecine Interne|February 25, 2023
[Medication reconciliation: Interests and limits]F Correard, R Arcani, M Montaleytang, et al.
BMC Geriatrics|April 22, 2020
Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trialF Correard, M Montaleytang, M Costa, et al.
Annales Pharmaceutiques Francaises|December 8, 2019
[Feedback on clinical oncology pharmacy]T Perez, M Montaleytang, C Boisseranc, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annales De Dermatologie Et De Venereologie|November 11, 2023
The value of pharmaceutical expertise in the detection and management of drug interactions with targeted therapies in melanomaB Demarez, C Gaudy, F Amatore, et al.
La Revue De Medecine Interne|February 25, 2023
[Medication reconciliation: Interests and limits]F Correard, R Arcani, M Montaleytang, et al.
BMC Geriatrics|April 22, 2020
Impact of medication review via tele-expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD): study protocol for a randomized controlled trialF Correard, M Montaleytang, M Costa, et al.
Annales Pharmaceutiques Francaises|December 8, 2019
[Feedback on clinical oncology pharmacy]T Perez, M Montaleytang, C Boisseranc, et al.
Pageof 1